DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
69 hedge funds and large institutions have $3.03M invested in DermTech, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 15 closing their positions.
357% more call options, than puts
Call options by funds: $32K | Put options by funds: $7K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 77 → 69 (-8)
42% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 19
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
70% less capital invested
Capital invested by funds: $10.2M → $3.03M (-$7.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCBWMS
Texas Capital Bank Wealth Management Services
Dallas,
Texas
|
+$90.4K |
| 2 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
+$54.2K |
| 3 |
VF
Virtu Financial
New York
|
+$22.1K |
| 4 |
SIC
Salem Investment Counselors
Winston Salem,
North Carolina
|
+$17.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$777K |
| 2 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$339K |
| 3 |
Millennium Management
New York
|
-$275K |
| 4 |
Jane Street
New York
|
-$131K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$124K |
DMTK Hedge Fund Activity: Q1 2024 in Review
69 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2024, worth a combined $3.03M — down 70% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of DMTK and 7 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 11 added.
The largest buyer was Texas Capital Bank Wealth Management Services, adding an estimated $90.4K. The largest seller was Morgan Stanley, cutting an estimated $777K.
- 69 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2024, down from 77 in Q4 2023.
- Funds reported $3.03M of DermTech, Inc. Common Stock stock for Q1 2024, down 70% quarter-over-quarter.
- 7 funds opened new DermTech, Inc. Common Stock positions in Q1 2024 and 15 closed out, a net change of -8 holders.
- The largest DermTech, Inc. Common Stock buyer in Q1 2024 was Texas Capital Bank Wealth Management Services, an estimated $90.4K added.
- The largest DermTech, Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $777K sold.
Based on aggregated 13F filings for Q1 2024.